Contract award · 25 Jul 2025

Secondary Blood Grouping and Sickle Testing

NHS Blood and Transplant awarded “Secondary Blood Grouping and Sickle Testing” to IBG Immucor Ltd for £6.24m. Awarded without open competition.

No competitionHealth & social careSouth West

Value £6.24m
WinnerIBG Immucor Ltd SME

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
NHS Blood and Transplant · Body governed by public law
Supplier
IBG Immucor Ltd SME
Value
£6,240,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Health & social care · Blood analysis services (CPV 85111810)
Timeline
  1. Contract date25 Jul 2025
  2. Published25 Jul 2025Published the same day

Description

NHSBT will award a Managed Service Contract for the supply of commercially available automated blood group testing equipment for use as a secondary testing technology for ABO and Rh D typing, antibody screening and identification, extended red cell phenotyping and HbAS (heterozygous sickle cell trait) screening for donor blood, tissues and stem cell (haemopoietic progenitor cells and therapeutic cells) samples.

About the supplier

More from NHS Blood and Transplant

All contracts

More won by IBG Immucor Ltd

All contracts

Recent health & social care contracts

Sector overview